Showing results (421-430 of 524) with videos related to
Sort By:
Pageof 53
The Lancet. Infectious Diseases|March 28, 2014
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospectsAlimuddin I Zumla, Stephen H Gillespie, Michael Hoelscher, et al.The Lancet. Infectious Diseases|April 18, 2015
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?Simone Lanini, Alimuddin Zumla, John P A Ioannidis, et al.Plos Pathogens|January 6, 2017
Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected PatientMirella Biava, Claudia Caglioti, Licia Bordi, et al.Antimicrobial Resistance and Infection Control|August 30, 2020
Antimicrobial resistance preparedness in sub-Saharan African countriesLinzy Elton, Margaret J Thomason, John Tembo, et al.Journal of Translational Medicine|February 7, 2026
TCRcloud: a global visualization tool for T-cell and B-cell receptor transcriptsEric de Sousa, Joana R Lérias, Carolina M Gorgulho, et al.Cells|May 13, 2026
Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal AdenocarcinomaAndreia Maia, Hasti Calá, Eric de Sousa, et al.Plos Neglected Tropical Diseases|December 9, 2020
Seroprevalence and associated risk factors of Dengue fever in Kassala state, eastern SudanArwa Elaagip, Khider Alsedig, Omnia Altahir, et al.The Lancet. Infectious Diseases|August 28, 2019
Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trialsSimone Lanini, John P A Ioannidis, Francesco Vairo, et al.BMJ Open|September 10, 2018
Effectiveness of service models and organisational structures supporting tuberculosis identification and management in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic reviewCharlotte C Heuvelings, Patrick F Greve, Sophia G de Vries, et al.Viruses|February 28, 2023
Hepatitis E Virus (HEV) in Makkah, Saudi Arabia: A Population-Based Seroprevalence StudyMai M El-Daly, Rajaa Al-Raddadi, Amany Alharbi, et al.Pageof 53